Human Vδ2 versus non-Vδ2 γδ T cells in antitumor immunity.
about
Comparative characterization of stroma cells and ductal epithelium in chronic pancreatitis and pancreatic ductal adenocarcinoma.Clinical applications of gamma delta T cells with multivalent immunity.γδ T-cell reconstitution after HLA-haploidentical hematopoietic transplantation depleted of TCR-αβ+/CD19+ lymphocytesγδ T cells and epigenetic drugs: A useful merger in cancer immunotherapy?Hyperactivation and in situ recruitment of inflammatory Vδ2 T cells contributes to disease pathogenesis in systemic lupus erythematosus.TCRγ4δ1-engineered αβT cells exhibit effective antitumor activityHuman Vδ2 T cells are a major source of interleukin-9.Human γδT-cell subsets and their involvement in tumor immunity.γδ T Cell-Mediated Immune Responses in Disease and TherapyMonitoring Circulating γδ T Cells in Cancer Patients to Optimize γδ T Cell-Based Immunotherapy.Ageing and latent CMV infection impact on maturation, differentiation and exhaustion profiles of T-cell receptor gammadelta T-cellsZoledronic acid boosts γδ T-cell activity in children receiving αβ+ T and CD19+ cell-depleted grafts from an HLA-haplo-identical donor.Critical role of butyrophilin 3A1 in presenting prenyl pyrophosphate antigens to human γδ T cellsAnalysis of tumor-infiltrating gamma delta T cells in rectal cancer.It May Seem Inflammatory, but Some T Cells Are Innately Healing to the Bone.Cytokine-mediated activation of human ex vivo-expanded Vγ9Vδ2 T cells.Zoledronate can induce colorectal cancer microenvironment expressing BTN3A1 to stimulate effector γδ T cells with antitumor activity.Proportions of blood-borne Vδ1+ and Vδ2+ T-cells are associated with overall survival of melanoma patients treated with ipilimumab.Activation status of γδ T cells dictates their effect on osteoclast generation and bone resorption.Editorial: "Recent Advances in Gamma/Delta T Cell Biology: New Ligands, New Functions, and New Translational Perspectives".Expression of non-secreted IL-4 is associated with HDAC inhibitor-induced cell death, histone acetylation and c-Jun regulation in human gamma/delta T-cells.CD20-Specific Immunoligands Engaging NKG2D Enhance γδ T Cell-Mediated Lysis of Lymphoma Cells.A bispecific nanobody approach to leverage the potent and widely applicable tumor cytolytic capacity of Vγ9Vδ2-T cells.γδ T Cells in Peripheral Blood of Glioma Patients.
P2860
Q33567742-90C0470F-BFA9-4206-8BF8-3FD1BCDC3DCCQ34677859-3D846701-5027-47C8-B1BF-75C2B7D4D02DQ35634919-43F392B7-86B1-460E-93A8-CD8463FCE4FAQ35799192-C6F51C7D-E841-4EAE-A8E7-BEC280FFB011Q36099417-3A4C26E2-065D-41E2-821B-37AFB54E8CDAQ37370559-4D9047F9-A2A0-4B81-92E8-801CAC1A50FCQ37398235-EB306B78-82A5-4E01-A286-DC3052024D9AQ37714642-D44D414C-F341-4A0E-BEF7-AD474F423031Q38271584-D0C6EAF4-35BE-4EE2-979B-EC5FF57D9244Q38310258-3014D42F-1018-4900-967B-4AB25371D53FQ38678058-853B7B09-3D2D-43AA-96B4-D0A5E3ED3178Q38875042-1CF65515-D5F0-4DD8-A0CE-316A6BABC74FQ39028978-F2A116DF-C481-415E-ADE7-CA6E75A21489Q39704837-743C5BA8-8AC4-4C8F-9FF0-057F08673D5AQ39748470-85A72905-C990-479C-9105-E6E83623CD20Q40207403-64762B75-C410-4DAB-8FCD-E627B56ACFF7Q40252845-57774947-1A30-4F88-AFC0-A2719A4DA266Q40355238-87270F1D-E9AB-4F9E-BF8F-97C9FB81E9A5Q40942283-4B1845DA-33AB-4537-BB6B-BBDA532A057DQ41061926-4DBD2F06-2B3B-4A0B-94C9-0B213F7C7776Q41981818-94F8652D-FD6C-4A5C-A22F-58A28D14A61EQ48124547-A561C16D-56D7-4B14-A26C-43C88A50C78DQ52731753-558D1F9E-3207-4681-A96D-C471482AD658Q55340793-5DCDB318-F471-4046-93AD-9B2289A25A59
P2860
Human Vδ2 versus non-Vδ2 γδ T cells in antitumor immunity.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Human Vδ2 versus non-Vδ2 γδ T cells in antitumor immunity.
@en
Human Vδ2 versus non-Vδ2 γδ T cells in antitumor immunity.
@nl
type
label
Human Vδ2 versus non-Vδ2 γδ T cells in antitumor immunity.
@en
Human Vδ2 versus non-Vδ2 γδ T cells in antitumor immunity.
@nl
prefLabel
Human Vδ2 versus non-Vδ2 γδ T cells in antitumor immunity.
@en
Human Vδ2 versus non-Vδ2 γδ T cells in antitumor immunity.
@nl
P2093
P2860
P356
P1433
P1476
Human Vδ2 versus non-Vδ2 γδ T cells in antitumor immunity
@en
P2093
Daniela Wesch
Dieter Kabelitz
Hans-Heinrich Oberg
P2860
P304
P356
10.4161/ONCI.23304
P577
2013-03-01T00:00:00Z